-transparent.png){kind=logo}
Immunohistochemical staining of invasive squamous cell carcinoma of the uterine cervix, stage IB to IV, with monoclonal antibodies against blood group antigens shows retained expression of the antigen in two thirds of the patients, regardless of stage. The over-all 5 year survival of the 115 patients was 60%, 71% in the antigen positive group, 37% in the antigen negative group. The loss of blood group antigen expression thus implies a worse prognosis in all stages of cervical carcinoma and could be used as a predictive marker.
Related Publications
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
November 1994,
Gynecologic oncology,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
January 1998,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
January 2007,
Zhonghua fu chan ke za zhi,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
March 1997,
Gynecologic oncology,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
April 2005,
Pathology international,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
January 2008,
Zhonghua fu chan ke za zhi,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
February 1983,
Gynecologic oncology,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
January 1988,
Gynecologic and obstetric investigation,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
April 1989,
Cancer,
A Lindgren, and
U Stendahl, and
T Brodin, and
A Lundblad, and
J Sällström, and
C Busch
July 1989,
Minerva ginecologica,
